Kristin Ardlie Selected Research

Kristin Ardlie Research Topics

4	Atherosclerosis 01/2024 - 11/2021
4	Obesity 01/2023 - 04/2006
4	Type 2 Diabetes Mellitus (MODY) 01/2012 - 06/2007
3	Insulin Resistance 10/2023 - 02/2010
3	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 05/2007
3	Neoplasms (Cancer) 01/2012 - 10/2004
2	Carcinogenesis 01/2012 - 02/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2024
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2023
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2023
1	Thalassemia 03/2023
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2021
1	Breast Neoplasms (Breast Cancer) 05/2012
1	Melanoma (Melanoma, Malignant) 05/2012
1	Rheumatoid Arthritis 01/2011
1	Genetic Risk Score 01/2011
1	Infections 01/2006
1	Hypertension (High Blood Pressure) 01/2006
1	Fibrosis (Cirrhosis) 10/2004
1	Chemical and Drug Induced Liver Injury 10/2004
1	Inflammation (Inflammations) 10/2004
1	Liver Diseases (Liver Disease) 10/2004

4	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 04/2006
3	Glucose (Dextrose)FDA LinkGeneric 02/2010 - 06/2007
2	Transcription Factors (Transcription Factor)IBA 01/2024 - 05/2012
2	RNA (Ribonucleic Acid)IBA 10/2023 - 11/2021
2	ProteomeIBA 10/2023 - 01/2022
1	ChemokinesIBA 02/2024
1	Insulin-Like Growth Factor Binding Protein 1IBA 10/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 05/2012
1	AndrogensIBA 05/2012
1	Sorafenib (BAY 43-9006)FDA Link 01/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2012
1	V 70 (V70)IBA 01/2012
1	VemurafenibIBA 01/2012
1	Hormones (Hormone)IBA 01/2012
1	AdiponectinIBA 01/2012
1	AutoantibodiesIBA 01/2011
1	Anti-Citrullinated Protein AntibodiesIBA 01/2011
1	Insulin (Novolin)FDA Link 02/2010
1	ORALIT (ORS)IBA 10/2009
1	LipidsIBA 06/2007
1	Triglycerides (Triacylglycerol)IBA 06/2007
1	Chemokine ReceptorsIBA 01/2006
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2006
1	CCR ReceptorsIBA 01/2006
1	AntibodiesIBA 10/2004

3	Therapeutics 02/2024 - 01/2012
2	Precision Medicine 01/2024 - 01/2022